Literature DB >> 12065545

Mycobacterium tuberculosis CDC1551 is resistant to reactive nitrogen and oxygen intermediates in vitro.

Marcia A Firmani1, Lee W Riley.   

Abstract

Resistance to reactive oxygen intermediates and reactive nitrogen intermediates in vitro of a clinical isolate of Mycobacterium tuberculosis (CDC1551) that caused a large outbreak of tuberculosis was compared to that of M. tuberculosis strains CB3.3, H37Rv, H37Ra, Erdman, RJ2E, C.C. 13, and C.C. 22 as well as M. bovis strains Ravenel and BCG. CDC1551 and CB3.3 were significantly more resistant to both hydrogen peroxide (H(2)O(2)) and acidified sodium nitrite than were the other strains tested. This biological phenotype may serve as an in vitro marker for clinical strains of M. tuberculosis likely to cause a large outbreak of tuberculosis.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12065545      PMCID： PMC128088          DOI： 10.1128/IAI.70.7.3965-3968.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  32 in total

1.  RFLP patterns and risk factors for recent tuberculosis transmission among hospitalized tuberculosis patients in Rio de Janeiro, Brazil.

Authors:  F C Fandinho; A L Kritski; C Hofer; H Júnior Conde; R M Ferreira; M H Saad; M G Silva; L W Riley; L S Fonseca
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 May-Jun       Impact factor: 2.184

2.  Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis.

Authors:  P S Jackett; V R Aber; D B Lowrie
Journal:  J Gen Microbiol       Date:  1978-01

3.  Induction of direct antimicrobial activity through mammalian toll-like receptors.

Authors:  S Thoma-Uszynski; S Stenger; O Takeuchi; M T Ochoa; M Engele; P A Sieling; P F Barnes; M Rollinghoff; P L Bolcskei; M Wagner; S Akira; M V Norgard; J T Belisle; P J Godowski; B R Bloom; R L Modlin
Journal:  Science       Date:  2001-02-23       Impact factor: 47.728

4.  Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2.

Authors:  I Garcia; R Guler; D Vesin; M L Olleros; P Vassalli; Y Chvatchko; M Jacobs; B Ryffel
Journal:  Lab Invest       Date:  2000-09       Impact factor: 5.662

5.  Growth of a highly virulent strain of Mycobacterium tuberculosis in mice of differing susceptibility to tuberculous challenge.

Authors:  C L Kelley; F M Collins
Journal:  Tuber Lung Dis       Date:  1999

6.  Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion.

Authors:  K Yu; C Mitchell; Y Xing; R S Magliozzo; B R Bloom; J Chan
Journal:  Tuber Lung Dis       Date:  1999

7.  Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates.

Authors:  M Denis
Journal:  Cell Immunol       Date:  1991-01       Impact factor: 4.868

8.  Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70 C.

Authors:  A A Grover; H K Kim; E H Wiegeshaus; D W Smith
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

9.  Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates.

Authors:  I E Flesch; S H Kaufmann
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages.

Authors:  J Chan; Y Xing; R S Magliozzo; B R Bloom
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307
View more
  12 in total

1.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

Review 2.  Intercepting signalling mechanism to control environmental biofouling.

Authors:  Smita Pal; Asifa Qureshi; Hemant J Purohit
Journal:  3 Biotech       Date:  2018-08-09       Impact factor: 2.406

3.  Low concentrations of nitric oxide exert a hormetic effect on Mycobacterium tuberculosis in vitro.

Authors:  William Benjamin Brugmann; Marcia A Firmani
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro.

Authors:  Marcia A Firmani; Lee W Riley
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

5.  Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival.

Authors:  Susanne Homolka; Stefan Niemann; David G Russell; Kyle H Rohde
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

6.  Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity.

Authors:  Jagadeeswara Rao Muvva; Sultan Ahmed; Rokeya Sultana Rekha; Sadaf Kalsum; Ramona Groenheit; Thomas Schön; Birgitta Agerberth; Peter Bergman; Susanna Brighenti
Journal:  J Infect Dis       Date:  2021-07-15       Impact factor: 5.226

7.  Resistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosis.

Authors:  Jonna Idh; Mekidim Mekonnen; Ebba Abate; Wassihun Wedajo; Jim Werngren; Kristian Ängeby; Maria Lerm; Daniel Elias; Tommy Sundqvist; Abraham Aseffa; Olle Stendahl; Thomas Schön
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

8.  Reduced susceptibility of clinical strains of Mycobacterium tuberculosis to reactive nitrogen species promotes survival in activated macrophages.

Authors:  Jonna Idh; Blanka Andersson; Maria Lerm; Johanna Raffetseder; Daniel Eklund; Hanna Woksepp; Jim Werngren; Mikael Mansjö; Tommy Sundqvist; Olle Stendahl; Thomas Schön
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

Review 9.  Nitric Oxide in the Pathogenesis and Treatment of Tuberculosis.

Authors:  Hamidreza Jamaati; Esmaeil Mortaz; Zeinab Pajouhi; Gert Folkerts; Mehrnaz Movassaghi; Milad Moloudizargari; Ian M Adcock; Johan Garssen
Journal:  Front Microbiol       Date:  2017-10-12       Impact factor: 5.640

Review 10.  Role of Oxidative Stress in the Pathology and Management of Human Tuberculosis.

Authors:  Madhur D Shastri; Shakti Dhar Shukla; Wai Chin Chong; Kamal Dua; Gregory M Peterson; Rahul P Patel; Philip M Hansbro; Rajaraman Eri; Ronan F O'Toole
Journal:  Oxid Med Cell Longev       Date:  2018-10-11       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.